Obesity Intervention Devices Market Update 2023: Revenue to Cross USD 407.6 Million 2031, Exclusive Report

The increasing prevalence of obesity worldwide is a major factor driving the growth of the global obesity intervention devices market. According to the World Health Organization (WHO), obesity rates have tripled since 1975, with approximately 1.9 billion adults overweight or obese as of 2016. This rise in obesity rates has led to an increase in health complications such as diabetes, cardiovascular disease, and certain types of cancer. As a result, there is a growing demand for effective obesity management devices.

One of the most commonly used obesity intervention devices is the gastric band. A gastric band is a silicone ring that is placed around the upper part of the stomach, which helps to limit the amount of food a person can eat. Gastric balloons, on the other hand, are temporary devices that are inserted into the stomach and filled with fluid to create a feeling of fullness. The gastric stimulator system, also known as the “pacemaker for the stomach,” uses electrical impulses to stimulate the stomach muscles and reduce feelings of hunger.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/5480

Some of the major companies

Apollo Endosurgery, Reshape Lifesciences, GI Dynamics, Allergan, Cousin Biotech, Johnson & Johnson, Asensus Surgical, A.M. I GmbH, Allurion Technologies, Inc., and Endalis

Obesity Intervention Devices Market Report Highlights

Gastric bands are the most commonly used obesity intervention device and are designed to restrict the amount of food a person can eat. The report highlights the increasing demand for gastric bands, driven by their effectiveness in helping individuals lose weight. It also identifies the key manufacturers of gastric bands, including Allergan Inc., Apollo Endosurgery, Inc., and ReShape Lifesciences, Inc.

Gastric balloons are temporary devices that are inserted into the stomach and filled with fluid to create a feeling of fullness. The report highlights the increasing popularity of gastric balloons, driven by their minimally invasive nature and potential to produce significant weight loss. It also identifies the key manufacturers of gastric balloons, including Apollo Endosurgery, Inc., ReShape Lifesciences, Inc., and Obalon Therapeutics, Inc.

Gastric stimulation systems, also known as the “pacemaker for the stomach,” use electrical impulses to stimulate the stomach muscles and reduce feelings of hunger. The report highlights the increasing demand for gastric stimulation systems, driven by their potential to provide a more targeted approach to obesity management. It also identifies the key manufacturers of gastric stimulation systems, including EnteroMedics, Inc., ReShape Lifesciences, Inc., and IntraPace, Inc.

The report also identifies hospitals and clinics as the key end-users of obesity intervention devices. It highlights the increasing demand for these devices in healthcare settings, driven by the rising prevalence of obesity and associated health complications such as diabetes, cardiovascular disease, and certain types of cancer. It also provides a regional analysis of the obesity intervention devices market, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The global obesity intervention devices market report provides a regional analysis of the market across North America, Europe, Asia-Pacific, and LAMEA. Each region has unique market trends and dynamics that impact the growth of the obesity intervention devices market.

North America is expected to hold the largest share of the obesity intervention devices market during the forecast period, driven by a high prevalence of obesity and associated health complications. The United States is the largest market for obesity intervention devices in North America, followed by Canada and Mexico. The region is also home to many key players in the market, such as Allergan Inc., Apollo Endosurgery, Inc., and ReShape Lifesciences, Inc.

Europe is also expected to see significant growth in the obesity intervention devices market, driven by increasing awareness about the health risks associated with obesity and a growing demand for effective treatment options. Germany, France, the UK, Italy, Spain, and the rest of Europe are the key markets in the region. The presence of major manufacturers such as Obalon Therapeutics, Inc. and Apollo Endosurgery, Inc. is also expected to drive market growth in Europe.

Asia-Pacific is expected to see the fastest growth in the obesity intervention devices market during the forecast period, driven by rising obesity rates and an increasing demand for effective treatment options. Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific are the key markets in the region. The increasing availability of advanced medical technologies and rising healthcare expenditure in countries such as China and India are also expected to drive market growth in Asia-Pacific.

LAMEA is expected to see moderate growth in the obesity intervention devices market during the forecast period, driven by increasing awareness about the health risks associated with obesity and a growing demand for effective treatment options. Brazil, Saudi Arabia, South Africa, and the rest

𝐏𝐔𝐑𝐂𝐇𝐀𝐒𝐄 𝐅𝐔𝐋𝐋 𝐑𝐄𝐏𝐎𝐑𝐓: https://www.alliedmarketresearch.com/obesity-intervention-devices-market/purchase-options